SZodixStudyAcademic Library

Dashboard Shelves Open access My library Inbox Notes Write Learn Alerts

More

Ask your library Notifications Quick cite Review

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Availability of and Access to Orphan Drugs · Study

ArticleShelves

ArticleAvailability of and Access to Orphan Drugs

Carl Rudolf Blankart2010

Article2010

Availability of and Access to Orphan Drugs

Carl Rudolf Blankart · Tom Stargardt · Jonas Schreyögg

87 citations·0/0 files stored·PharmacoEconomics

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Health Systems, Economic Evaluations, Quality of Life Biosimilars and Bioanalytical Methods

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 87 citations exist upstream.

References

2007Economics of New Oncology Drug Development 2007Assessing the economic challenges posed by orphan drugs 2003Prices And Availability Of Pharmaceuticals: Evidence From Nine Countries 2008Market incentives and pharmaceutical innovation 2006Adopting Orphan Drugs — Two Dozen Years of Treating Rare Diseases 2008Incentives for orphan drug research and development in the United States 2006Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products 2005AfDB Group Annual Report 2004

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2008Incentives for orphan drug research and development in the United Statesarticle · 3 shared references 2010Policies and Incentives for Promoting Innovation in Antibiotic Researcharticle · 2 shared references 2014Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Frameworkarticle · 2 shared references 2010Access to orphan drugs despite poor quality of clinical evidencearticle · 2 shared references 2010A discrete choice experiment investigating preferences for funding drugs used to treat orphan diseases: an exploratory studyarticle · 2 shared references 2012Strategic Corporate Social Responsibility and Orphan Drug Development: Insights from the US and the EU Biopharmaceutical Industryarticle · 2 shared references

Details

Year2010

Typearticle

Published2010-11-13

VenuePharmacoEconomics

ISSN-L1170-7690

Languageen

Citations87

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.2165/11539190-000000000-00000

openalex_workW1578255890

Links

Imported from OpenAlex (CC0) — nothing here is generated.